相关实验视频

Updated: May 13, 2026

Potentiation of Anticancer Antibody Efficacy by Antineoplastic Drugs: Detection of Antibody-drug Synergism Using the Combination Index Equation
15:04

Potentiation of Anticancer Antibody Efficacy by Antineoplastic Drugs: Detection of Antibody-drug Synergism Using the Combination Index Equation

Published on: January 19, 2019

12.1K

在先前接受治疗的高级非状NSCLC中,达托帕马布德鲁克斯泰康的成本效益

Ying Song1

  • 1Department of Pharmacy, Jining No. 1 People's Hospital, Jining, Shandong, China.

Medicine
|May 19, 2025
PubMed
概括

在美国,达托帕马布德鲁克斯泰康 (Dato-DXd) 对晚期非状非小细胞肺癌没有成本效益.为了达到15万美元/QALY支付意愿的门,需要大幅降低Dato-DXd的价格.

关键词:
在NSCLCLC中,我们可以看到.经济效益性 经济效益性数据库 Deruxtecan 的数据库.分隔的生存模型.经质量调整的寿命年数.

更多相关视频

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts10:27

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

7.2K
Multiparametric Tumor Organoid Drug Screening Using Widefield Live-Cell Imaging for Bulk and Single-Organoid Analysis12:41

Multiparametric Tumor Organoid Drug Screening Using Widefield Live-Cell Imaging for Bulk and Single-Organoid Analysis

Published on: December 23, 2022

4.7K

相关概念视频

Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...